PT Diagnos Laboratorium Utama Tbk
IDX:DGNS.JK
246 (IDR) • At close October 30, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) IDR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 10,244.906 | 28,010.679 | 44,719.856 | 16,538.27 | 1,393.393 | 1,537.333 | 1,303.442 |
Short Term Investments
| 1,695.879 | 2,542.611 | 6,507.346 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 11,940.786 | 30,553.29 | 51,227.202 | 16,538.27 | 1,393.393 | 1,537.333 | 1,303.442 |
Net Receivables
| 38,280.329 | 49,454.502 | 73,939.062 | 81,273.273 | 7,451.321 | 8,364.871 | 4,977.912 |
Inventory
| 5,141.949 | 6,566.943 | 7,759.935 | 5,812.86 | 2,123.154 | 1,073.601 | 928.376 |
Other Current Assets
| 32,442.384 | 31,797.775 | 20,937.747 | 1,529.662 | 451.819 | 160 | 26.809 |
Total Current Assets
| 87,805.447 | 118,372.511 | 153,863.946 | 105,154.066 | 11,419.687 | 11,135.804 | 7,209.73 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 164,248.304 | 109,219.348 | 87,106.943 | 20,107.635 | 16,364.829 | 9,144.151 | 492.978 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 720.427 | 681.12 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 720.427 | 681.12 | 0 | 0 | 0 | -4,158.588 | -785.437 |
Long Term Investments
| 12,950.5 | 9,301.307 | 0 | 0 | 28,137.65 | 4,084.452 | 709 |
Tax Assets
| 1,031.487 | 1,019.942 | 1,011.904 | 762.699 | 0 | 74.136 | 76.437 |
Other Non-Current Assets
| 4,718.97 | 1,341.667 | 0 | 6,550.246 | 3,300 | 4,158.588 | 785.437 |
Total Non-Current Assets
| 183,669.689 | 121,563.384 | 88,118.847 | 27,420.581 | 47,802.478 | 13,302.739 | 1,278.415 |
Total Assets
| 271,475.136 | 239,935.894 | 241,982.794 | 132,574.647 | 59,222.165 | 24,438.544 | 8,488.144 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 6,089.968 | 3,077.768 | 4,523.618 | 15,824.616 | 2,035.439 | 1,952.257 | 2,544.656 |
Short Term Debt
| 4,255.393 | 4,140.345 | 2,965.938 | 766.802 | 562.605 | 5,223.84 | 112.805 |
Tax Payables
| 0 | 395.389 | 312.558 | 119.557 | 111.064 | 3.153 | 0 |
Deferred Revenue
| 651.534 | 893.769 | 312.558 | 119.557 | 111.064 | 3.153 | 0 |
Other Current Liabilities
| 3,447.312 | 2,379.76 | 18,826.225 | 13,900.972 | 6,407.213 | 3,599.45 | 574.283 |
Total Current Liabilities
| 14,444.207 | 10,491.641 | 26,628.339 | 30,611.948 | 9,116.321 | 10,778.7 | 3,231.744 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 51,004.327 | 9,357.926 | 2,887.824 | 1,951.036 | 2,584.122 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 342.51 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 7.117 | 0 | 0 |
Other Non-Current Liabilities
| 10,436.182 | 9,658.15 | 10,666.181 | 945.282 | 712.703 | 394.258 | 2,038.031 |
Total Non-Current Liabilities
| 61,440.509 | 19,016.076 | 13,554.005 | 2,896.318 | 3,646.452 | 394.258 | 2,038.031 |
Total Liabilities
| 75,884.716 | 29,507.717 | 40,182.343 | 33,508.266 | 12,762.773 | 11,172.958 | 5,269.776 |
Equity: | |||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 31,250 | 31,250 | 31,250 | 25,000 | 25,000 | 1,000 | 250 |
Retained Earnings
| 131,517.643 | 145,173.449 | 132,508.559 | 74,205.053 | 21,518.515 | 12,243.924 | 2,979.171 |
Accumulated Other Comprehensive Income/Loss
| -3,883.946 | -2,701.995 | 1,335.169 | -167.647 | -88.097 | -7.313 | -39.777 |
Other Total Stockholders Equity
| 36,706.723 | 36,706.723 | 36,706.723 | 28.975 | 28.975 | 28.975 | 28.975 |
Total Shareholders Equity
| 195,590.42 | 210,428.177 | 201,800.45 | 99,066.381 | 46,459.393 | 13,265.586 | 3,218.369 |
Total Equity
| 195,590.42 | 210,428.177 | 201,800.45 | 99,066.381 | 46,459.393 | 13,265.586 | 3,218.369 |
Total Liabilities & Shareholders Equity
| 271,475.136 | 239,935.894 | 241,982.794 | 132,574.647 | 59,222.165 | 24,438.544 | 8,488.144 |